CVS Group Plc (LON:CVSG) had its price target lifted by analysts at Investec from GBX 995 ($12.43) to GBX 1,085 ($13.56) in a report issued on Monday. The firm presently has an “add” rating on the stock. Investec’s price objective indicates a potential upside of 4.97% from the stock’s previous close.

CVSG has been the subject of a number of other reports. N+1 Singer reissued a “corporate” rating on shares of CVS Group Plc in a report on Friday, September 23rd. Peel Hunt reissued a “buy” rating and issued a GBX 1,000 ($12.49) price target on shares of CVS Group Plc in a report on Thursday. Finally, Berenberg Bank boosted their price target on CVS Group Plc from GBX 910 ($11.37) to GBX 1,000 ($12.49) and gave the stock a “buy” rating in a report on Thursday, October 20th.

Shares of CVS Group Plc (LON:CVSG) opened at 1040.00 on Monday. The firm’s market cap is GBX 623.98 million. CVS Group Plc has a 52-week low of GBX 645.00 and a 52-week high of GBX 1,056.00. The firm has a 50-day moving average price of GBX 878.00 and a 200-day moving average price of GBX 839.21.

The firm also recently disclosed a dividend, which will be paid on Friday, December 9th. Stockholders of record on Thursday, November 24th will be given a GBX 3.50 ($0.04) dividend. The ex-dividend date is Thursday, November 24th. This represents a dividend yield of 0.37%. This is an increase from CVS Group Plc’s previous dividend of $3.00.

WARNING: “CVS Group Plc (CVSG) PT Raised to GBX 1,085” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright law. The correct version of this article can be viewed at

In other CVS Group Plc news, insider Richard A. Connell acquired 2,109 shares of the stock in a transaction dated Friday, October 28th. The stock was acquired at an average price of GBX 878 ($10.97) per share, with a total value of £18,517.02 ($23,134.71). Also, insider Simon Innes acquired 5,750 shares of the stock in a transaction dated Tuesday, November 15th. The stock was acquired at an average cost of GBX 867 ($10.83) per share, with a total value of £49,852.50 ($62,284.48).

About CVS Group Plc

CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals.

Receive News & Stock Ratings for CVS Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group Plc and related stocks with our FREE daily email newsletter.